Punicic acid is an ω-5 fatty acid capable of inhibiting breast cancer proliferation

International Journal of Oncology

Volumn 36, Issue 2, 2010, Pages 421-426

  Grossmann, Michael E ^a   Mizuno, Nancy K ^a   Schuster, Todd ^a   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Breast cancer; Oxidation; Pomegranate

Indexed keywords

ALPHA TOCOTRIENOL; BISINDOLYMALEIMIDE I; LONG CHAIN FATTY ACID; OMEGA 5 FATTY ACID; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PUNICIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FATTY ACIDS; FEMALE; HUMANS; LINOLENIC ACIDS; LIPID PEROXIDATION; PLANT EXTRACTS; PROTEIN KINASE C; PUNICACEAE;

EID: 75449090447     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000515     Document Type: Article

References (39)

1. Syed DN, Afaq F and Mukhtar H: Pomegranate derived products for cancer chemoprevention. Semin Cancer Biol 17: 377-385, 2007.
2. Jurenka JS: Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev 13: 128-144, 2008.
3. Moneam NM, el Sharaky AS and Badreldin MM: Oestrogen content of pomegranate seeds. J Chromatogr 438: 438-442, 1988.
4. Belury MA: Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 132: 2995-2998, 2002.
5. Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51: 1479-1483, 1973.
6. Dyerberg J, Bang HO and Hjorne N: Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28: 958-966, 1975.
7. Lansky EP and Newman RA: Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109: 177-206, 2007.
8. Stark AH, Crawford MA and Reifen R: Update on alpha-linolenic acid. Nutr Rev 66: 326-332, 2008.
9. Bhattacharya A, Banu J, Rahman M, Causey J and Fernandes G: Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17: 789-810, 2006.
10. Lansky EP, Harrison G, Froom P and Jiang WG: Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs 23: 121-122, 2005.
11. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A and Cleary MP: Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98: 370-379, 2008.
12. Miglietta A, Bozzo F, Bocca C, et al: Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett 234: 149-157, 2006.
13. Kamal-Eldin A and Appelqvist LA: The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31: 671-701, 1996.
14. Takai Y, Kishimoto A, Kikkawa U, Mori T and Nishizuka Y: Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Commun 91: 1218-1224, 1979.
15. Kishimoto A, Takai Y, Mori T, Kikkawa U and Nishizuka Y: Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273-2276, 1980.
16. Tappel AL: Protection against free radical lipid peroxidation reactions. Adv Exp Med Biol 97: 111-131, 1977.
17. Frankel EN: Secondary products of lipid oxidation. Chem Phys Lipids 44: 73-85, 1987.
18. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK and Yu MC: Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma. Cancer Causes Control 13: 287-293, 2002.
19. Halliwell B: Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Act Neurol Scan (Suppl) 126: 23-33, 1989.
20. Hu W, Feng Z and Eveleigh J: The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23: 1781-1789, 2002.
21. Sander CS, Hamm F, Elsner P and Thiele JJ: Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 148: 913-922, 2003.
22. Berliner JA and Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727, 1996.
23. Gago-Dominguez M, Castelao JE, Pike M, Sevanian A and Haile RW: Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev 14: 2829-2839, 2005.
24. Gago-Dominguez M, Jiang X and Castelao JE: Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res 9: 201-211, 2007.
25. González MJ and Riordan NH: The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary. Medical Hypoth 46: 503-504, 1996.
26. Coursin DB, Cihla HP, Sempf J, Oberley TD and Oberley LW: An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung. Histol Histopathol 11: 851-860, 1996.
27. Hileman EO, Liu J, Albitar M, Keating MJ and Huang P: Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 53: 209-219, 2004.
28. Oberley TD and Oberley LW: Antioxidant enzyme levels in cancer. Histol Histopathol 12: 525-535, 1997.
29. Cejas P, Casado E, Belda-Iniesta C, et al: Implication of oxidation stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15: 707-719, 2004.
30. Chandra J, Samali A and Orrenius S: Triggering and modulation of apoptosis by oxidative stress. Free Rad Biol Med 29: 323-333, 2000.
31. Ozben T: Oxidative stress and apoptosis: impact on cancer theory. J Pharmaceut Sci 96: 2181-2196, 2007.
32. Albright CD, Klem E, Shah AA and Gallagher P: Breast cancer cell-targeted oxidative stress: Enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation Exp Molec Pathol 79: 118-125, 2005.
33. Albright CD, Salganik RI and van Dyke T: Dietary depletion of vitamin E and vitamin A inhibits mammary tumor growth and metastasis in transgenic mice. J Nutr 134: 1139-1144, 2004.
34. Salganik RI, Albright CD, Rodgers J, et al: Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21: 909-914, 2000.
35. Stoll BA: n-3 Fatty acids and lipid peroxidation in breast cancer inhibition. Br J Nutr 87: 193-198, 2002.
36. Rigas B and Sun Y: Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br J Cancer 98: 1157-1160, 2008.
37. Jude S, Roger S, Martel E, et al: Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 90: 299-325, 2006.
38. Griner EM and Kazanietz MG: Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294, 2007.
39. Grossmann ME, Mizuno NK, Dammen ML, Schuster T, Ray A and Cleary MP: Eleostearic acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism. Cancer Prev Res 2: 879-886, 2009.